Resonance Specialties to buy manufacturing unit from promoter group for Rs 29.98 cr

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹147.00

prior close

₹154.35

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+4.6% vs market

Specialty Chemicals peers, median of 94sector-0.1%+5.1% vs sector

On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 5.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+0.4+4.6-0.1+5.1

Next day

+10.2+1.7+8.5+0.4+9.8

+15.7+2.1+13.7+0.8+14.9

+16.2+2.1+14.1+0.9+15.3

+21.2+2.1+19.1+0.9+20.3

+24.5+1.9+22.6+0.7+23.7

+19.7+2.4+17.3+1.5+18.2

15d

+13.3+3.0+10.2+1.4+11.9

+9.9+3.7+6.2+3.4+6.5

+29.3+1.6+27.7+0.4+28.9

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved buying a manufacturing facility in Mandideep, MP from Kaygee Laboratories (promoter group) for Rs 29.98 cr. Unit makes intermediates and APIs for the company on job work basis and is WHO Geneva approved. Deal is at arms length and subject to shareholder approval. Acquisition will secure production and cut outsourcing costs. Q1 FY27 revenue grew to Rs 32.58 cr from Rs 21.27 cr YoY; PAT jumped to Rs 5.74 cr from Rs 1.63 cr.

Likely market impact

Buying in-house manufacturing of intermediates and APIs to cut outsourcing costs. Related party deal needs shareholder nod.